Insulet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. 

CEO
Ashley A. McEvoy
CEOAshley A. McEvoy
Employees
5,400
Employees5,400
Headquarters
Acton, Massachusetts
HeadquartersActon, Massachusetts
Founded
2000
Founded2000
Employees
5,400
Employees5,400

PODD Key Statistics

Market cap
14.39B
Market cap14.39B
Price-Earnings ratio
59.51
Price-Earnings ratio59.51
Dividend yield
Dividend yield
Average volume
895.31K
Average volume895.31K
High today
$209.32
High today$209.32
Low today
$202.52
Low today$202.52
Open price
$202.93
Open price$202.93
Volume
886.74K
Volume886.74K
52 Week high
$354.88
52 Week high$354.88
52 Week low
$202.44
52 Week low$202.44

Stock Snapshot

With a market cap of 14.39B, Insulet(PODD) trades at $204.30. The stock has a price-to-earnings ratio of 59.51.

During the trading session on 2026-04-03, Insulet(PODD) shares reached a daily high of $209.32 and a low of $202.52. At a current price of $204.30, the stock is +0.9% higher than the low and still -2.4% under the high.

Trading activity shows a volume of 886.74K, compared to an average daily volume of 895.31K.

Over the past 52 weeks, Insulet(PODD) stock has traded between a high of $354.88 and a low of $202.44.

Over the past 52 weeks, Insulet(PODD) stock has traded between a high of $354.88 and a low of $202.44.

PODD News

Simply Wall St 4d
Is Insulet’s New CCO Hire a Subtle Reset of Its Global Commercial Strategy?

Insulet Corporation recently appointed Mike Panos as Executive Vice President and Chief Commercial Officer, placing him in charge of the company’s global commer...

Is Insulet’s New CCO Hire a Subtle Reset of Its Global Commercial Strategy?
TipRanks 4d
Insulet appoints Panos as Chief Commercial Officer

Insulet (PODD) announced the appointment of Mike Panos as Executive Vice President, Chief Commercial Officer, effective immediately. In this role, Panos will le...

Analyst ratings

93%

of 27 ratings
Buy
92.6%
Hold
3.7%
Sell
3.7%

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.